The global plasmid purification market has witnessed significant growth over recent years owing to rising applications in gene therapy and DNA vaccination. Plasmids find applications in DNA vaccines, gene therapy, genetic engineering, protein production through molecular cloning. They are used to replicate DNA fragments through cell transfection processes. Advantages such as effective expression of genes, stability and ease of manipulation over viruses have boosted their adoption rate over the years.
The plasmid purification market is estimated to be valued at USD 1.98 Billion in 2024 and is expected to reach USD 4.21 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.
Key Takeaways
Key players operating in the plasmid purification market are Merck KGaA, QIAGEN, Thermo Fisher Scientific, Inc., Takara Bio, Promega Corporation, Zymo Research, MP BIOMEDICALS, New England Biolabs, MCLAB, Agilent Technologies Inc., Illumina Inc., and Applied Biological Materials Inc. These key players are focused on developing innovative kits and devices for plasmid isolation with improved performance.
The Plasmid Purification Market Demand is increasing owing to rising RD investments in gene therapy and DNA vaccines. Growing prevalence of cancer and genetic disorders is also driving research in gene and cell therapies which require high-quality plasmids. This growing focus on novel therapy development is positively impacting the market growth.
Get More Insights on- Plasmid Purification Market
